Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
复制标题
鼻咽癌外显子组和基因组测序鉴定NF-κB通路激活突变
DOI:
10.1038/ncomms14121
复制
发表时间:
2017-01-18
影响因子:
16.6
通讯作者:
Lo KW
中科院分区:
文献类型:
--
作者:
Li YY;Chung GT;Lui VW;To KF;Ma BB;Chow C;Woo JK;Yip KY;Seo J;Hui EP;Mak MK;Rusan M;Chau NG;Or YY;Law MH;Law PP;Liu ZW;Ngan HL;Hau PM;Verhoeft KR;Poon PH;Yoo SK;Shin JY;Lee SD;Lun SW;Jia L;Chan AW;Chan JY;Lai PB;Fung CY;Hung ST;Wang L;Chang AM;Chiosea SI;Hedberg ML;Tsao SW;van Hasselt AC;Chan AT;Grandis JR;Hammerman PS;Lo KW
Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer characterized by Epstein-Barr virus (EBV) infection and dense lymphocyte infiltration. The scarcity of NPC genomic data hinders the understanding of NPC biology, disease progression and rational therapy design. Here we performed whole-exome sequencing (WES) on 111 micro-dissected EBV-positive NPCs, with 15 cases subjected to further whole-genome sequencing (WGS), to determine its mutational landscape. We identified enrichment for genomic aberrations of multiple negative regulators of the NF-κB pathway, including CYLD, TRAF3, NFKBIA and NLRC5, in a total of 41% of cases. Functional analysis confirmed inactivating CYLD mutations as drivers for NPC cell growth. The EBV oncoprotein latent membrane protein 1 (LMP1) functions to constitutively activate NF-κB signalling, and we observed mutual exclusivity among tumours with somatic NF-κB pathway aberrations and LMP1-overexpression, suggesting that NF-κB activation is selected for by both somatic and viral events during NPC pathogenesis. Nasopharyngeal cancer is frequently characterized by Epstein-Barr virus infection. Here, using genomic analyses, the authors find that the tumours harbour mutations in genes involved in the NF-κB signalling pathway or overexpress a viral oncoprotein, latent membrane protein 1.